grant
Kainomyx — Antimalarial Drug (2021)
Metadata
| Source Table | grants |
| Source ID | 9DPzJrUZkm |
| Description | to Kainomyx, $4,000,000, 2021-09 |
| Source URL | coefficientgiving.org/grants/ |
| Parent | ULjDXpSLCI |
| Children | — |
| Created | Mar 12, 2026, 5:54 AM |
| Updated | Mar 19, 2026, 8:57 PM |
| Synced | Mar 19, 2026, 8:57 PM |
Record Data
id | 9DPzJrUZkm |
organizationId | Coefficient Giving(organization) |
granteeId | Kainomyx |
orgEntityId | Coefficient Giving(organization) |
orgDisplayName | — |
granteeEntityId | — |
granteeDisplayName | Kainomyx |
name | Kainomyx — Antimalarial Drug (2021) |
amount | 4000000 |
currency | USD |
period | — |
date | 2021-09 |
status | — |
source | coefficientgiving.org/funds/ |
notes | [Other Scientific Research Areas] Open Philanthropy recommended an investment of $4,000,000 in Kainomyx to develop and produce new drugs to treat malaria and other parasitic diseases, such as cryptosporidiosis and toxoplasmosis. If effective, the new drugs would act by inhibiting cytoskeletal protei… |
programId | B4pZkOtjSk |
dataSourceId | — |
Source Check Verdicts
confirmed95% confidence
Last checked: 4/3/2026
[deterministic-row-match] Deterministic match: grantee, amount, date matched in source snapshot (2714 rows)
Debug info
Thing ID: 9DPzJrUZkm
Source Table: grants
Source ID: 9DPzJrUZkm